ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2024

News provided by

04 Apr, 2024, 08:42 GMT

Zinzino group revenue increased with a total of 14 % in Q1 compared with the previous year.

GOTHENBURG, Sweden, April 4, 2024 /PRNewswire/ -- The revenue in March for Zinzino's sales markets increased by 9% and amounted to SEK 148.9 (136.2) million. Faun Pharma's external sales decreased with 1 % and amounted to SEK 9.7 (9.8) million. Overall, the Group increased revenues by 9% to SEK 158.6 (146.0) million compared with the previous year.

The group revenue increased with 14 % for Q1 2024 compared with the first quarter last year and amounted to SEK 450.4 (393.7) million.

Revenues were distributed as follows:

Regions, mSEK	24-mar	23-mar	Change	Q1 2024	Q1 2023	Change
The Nordics	22.6	26.8	-16 %	66.8	73.6	-9 %
Central Europe	41.7	35.5	17 %	117.8	90.9	30 %
East Europe	32.1	34.6	-7 %	93.3	92.5	1 %
South & West Europe	25.7	18.7	37 %	70.7	49,0	44 %
The Baltics	7.9	7.7	3 %	23.6	21.1	12 %
North America	12.7	7,0	81 %	34.7	19.6	77 %
Asia-Pacific	5,0	4.5	11 %	12.7	15.6	-19 %
Africa	1.2	1.4	-14 %	3.3	3.8	-13 %
Zinzino	148.9	136.2	9 %	422.9	366.1	16 %
Faun Pharma	9.7	9.8	-1 %	27.5	27.6	0 %
Zinzino Group	158.6	146.0	9 %	450.4	393.7	14 %

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa